Invesco Biotechnology & Genome ETF (PBE)
NYSEARCA: PBE · Real-Time Price · USD
66.32
+1.13 (1.73%)
Jul 9, 2025, 9:32 AM - Market open
PBE Holdings Information
PBE is an equity ETF with a total of 33 individual holdings. The top holdings are Illumina stock at 5.81%, Alnylam Pharmaceuticals at 5.44%, Royalty Pharma at 5.29%, Amgen at 5.08%, and Vertex Pharmaceuticals at 4.90%.
Total Holdings
33
Top 10 Percentage
47.68%
Asset Class
Equity
ETF Category
Health
Assets
228.63M
PE Ratio
20.44
Sector Allocation
Top 25 Holdings
As of Jul 3, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | ILMN | Illumina, Inc. | 5.81% |
2 | ALNY | Alnylam Pharmaceuticals, Inc. | 5.44% |
3 | RPRX | Royalty Pharma plc | 5.29% |
4 | AMGN | Amgen Inc. | 5.08% |
5 | VRTX | Vertex Pharmaceuticals Incorporated | 4.90% |
6 | GILD | Gilead Sciences, Inc. | 4.87% |
7 | BMRN | BioMarin Pharmaceutical Inc. | 4.71% |
8 | UTHR | United Therapeutics Corporation | 4.45% |
9 | AVXL | Anavex Life Sciences Corp. | 3.80% |
10 | BPMC | Blueprint Medicines Corporation | 3.33% |
11 | QGEN | Qiagen N.V. | 2.86% |
12 | PTGX | Protagonist Therapeutics, Inc. | 2.85% |
13 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.83% |
14 | CDNA | CareDx, Inc | 2.83% |
15 | EXEL | Exelixis, Inc. | 2.78% |
16 | NBIX | Neurocrine Biosciences, Inc. | 2.73% |
17 | DVAX | Dynavax Technologies Corporation | 2.72% |
18 | INCY | Incyte Corporation | 2.72% |
19 | TGTX | TG Therapeutics, Inc. | 2.70% |
20 | RGEN | Repligen Corporation | 2.70% |
21 | COLL | Collegium Pharmaceutical, Inc. | 2.67% |
22 | PTCT | PTC Therapeutics, Inc. | 2.66% |
23 | HALO | Halozyme Therapeutics, Inc. | 2.57% |
24 | VCYT | Veracyte, Inc. | 2.55% |
25 | FOLD | Amicus Therapeutics, Inc. | 2.54% |
As of Jul 3, 2025